Ozempic and Type 1 Diabetes: What the Science Says About Safety and Indications
Wondering if Ozempic works for type 1 diabetes? Here's what research actually shows about safety, risks, and why this medication isn't approved for autoimmune diabetes.
The latest updates on Ozempic, Mounjaro, Wegovy and GLP-1 treatments
Wondering if Ozempic works for type 1 diabetes? Here's what research actually shows about safety, risks, and why this medication isn't approved for autoimmune diabetes.
Wondering if you can safely take supplements while using GLP-1 weight loss pens? Here's what the current evidence actually says about vitamins, protein powders, and other common supplements alongside semaglutide and tirzepatide.
The parallel market for GLP-1 pens offers accessible prices but carries serious risks. OzemNews explains what patients need to understand before sourcing medications outside authorized channels.
Starting GLP-1 treatment is a personal health decision, but explaining it to loved ones can feel overwhelming. Here's how to protect your peace while having these conversations.
Discover how oral semaglutide could expand GLP-1 treatment access in Brazil, overcoming injection barriers like refrigeration needs and needle phobia.
If your GLP-1 medication seems to have plateaued, here's what physicians actually look at before making changes to your treatment plan.
Don't be fooled by the sticker price. Importing GLP-1 pens comes with hidden costs that can quickly eat up your savings.
Wondering why your bowel movements changed on GLP-1 medication? Here's what clinical trials and medical literature actually say about constipation with Ozempic and Mounjaro.
Stopping GLP-1 therapy prematurely happens more often than it should. Here's what structured medical follow-up does differently—and why it matters for lasting results.
Why does weight come back after stopping GLP-1 medications like semaglutide? The answer lies in hunger hormones, metabolic adaptation, and ancient survival mechanisms that kick in when the body senses fat loss. Learn what science says about the rebound pattern and what you can do about it.
Researchers are exploring how GLP-1 medications interact with gut bacteria. Here's what we know so far about this emerging area of study.
Answer a few quick questions and get tailored guidance for your treatment.
or download the app